METTL3 and gastric cancer: METTL3 reduces the expression of anti-apoptotic protein Bcl-2 through m6A methylation modification, while the pro-apoptotic protein Bax is relatively increased, which then activates Caspase-3 to promote the apoptotic pathway in GC (Figure 3) (92).